 - Impairment of gastrointestinal GI function or GI disease that may significantly alter the absorption of BJM120 e.g., ulcerative diseases, uncontrolled nausea, vomiting, diarrhea, malabsorption syndrome, or small bowel resection; patients with unresolved diarrhea will be excluded as previously indicated; patients must be able to swallow capsules whole 